Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 11690850
Inhibitors of receptor interacting protein kinase I for the treatment of disease
granted -
US 11690919
Endolysosomal targeting conjugates for improved delivery of cargo molecules to the endolysosomal compartment of target cells
granted -
US 11690901
Southern cattle tick vaccine product
granted -
US 11690827
Methods for treating ocular Demodex using lotilaner formulations
granted -
US 11691987
Bicyclic heterocyclyl derivatives as IRAK4 inhibitors
granted -
US 11690895
Compositions and methods of interferon alpha binding proteins
granted -
US 11690851
Methods and compositions comprising ursolic acid and/or resveratrol for treating diabetes, or cancer
granted -
US 11690860
Treatment of HCV infected patients with cirrhosis
granted -
US 11690853
Non-hormonal steroid modulators of NF-κβ for treatment of disease
granted -
US 11690836
Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions, and uses thereof
granted -
US 11690826
Methods for treating demodex blepharitis using lotilaner formulations
granted -
US 11690829
Use of gaboxadol for the treatment of non-24 hour sleep-wake disorder
granted -
US 11690825
20-HETE receptor (GPR75) antagonists and methods of use
granted -
US 11690828
Treatment of CNS diseases with sGC stimulators
granted -
US 11690837
Methods of improving cell-based therapy
granted -
US 11690915
Ras inhibitors
granted -
US 11692032
Anti-LAG3 antibodies and uses thereof
granted -
US 11691972
Compounds for targeted degradation of BRD9
granted -
US 11691992
Oxaborole analogs and uses thereof
granted -
US 11692176
Halogenation of complex organic compounds
granted -
US 11692184
Thermostable RNA-guided endonucleases and methods of use thereof
granted -
US 11693015
Methods of treating patients afflicted with irritable bowel syndrome, inflammatory bowel disease or chronic gastrointestinal functional disorders based on assessment of intestinal barrier function
granted -
US 11692229
Fast diagnosis and personalized treatments for acne
granted -
US 11692018
TGF-β polypeptides
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.